Clinic
Valley View Hospital Association
Valley View Hospital Association was paid $4.46M by Medicaid between Jan 2018 and Nov 2024, across 123 billing codes. Its largest line is 99283, emergency room visit (moderate) — 23% of everything it billed.
33Billing provider infoVALLEY VIEW HOSPITAL ASSOCIATION
GLENWOOD SPRINGS, CO 81601
GLENWOOD SPRINGS, CO 81601
33aNPI1982668133assigned 04/14/2006
33bProvider typeEmergency Care Clinic/Center
28Total paid$4.46M
24GClaims115,323
24DCodes billed123
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Emergency Care Clinic/Center providers in Colorado
Rank by total paid#4 of 23
Median peer was paid$1.29M
This provider vs. median3.5×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 20,356 | $658K | |
| 2019 | 25,240 | $762K | |
| 2020 | 13,930 | $506K | |
| 2021 | 20,786 | $805K | |
| 2022 | 17,834 | $621K | |
| 2023 | 12,125 | $846K | |
| 2024incomplete | 5,052 | $259K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 23% | 7,147 | 5,982 | $1.01M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 11% | 6,226 | 5,292 | $506K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 7.3% | 2,701 | 2,098 | $325K |
| 96361 | Intravenous infusion, hydration; each additional hour | 5.5% | 1,657 | 947 | $246K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 4.4% | 1,033 | 462 | $198K |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 4.3% | 226 | 205 | $193K |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 4.0% | 1,478 | 1,378 | $179K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 3.9% | 5,263 | 1,515 | $176K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 3.3% | 1,501 | 1,268 | $147K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 2.9% | 3,273 | 999 | $130K |
| 80053 | Comprehensive metabolic panel | 2.9% | 8,502 | 5,908 | $129K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 2.6% | 4,695 | 1,321 | $117K |
111 more codes
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 2.4% | 297 | $108K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 2.1% | 3,556 | $93K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 2.0% | 1,044 | $89K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 1.3% | 1,809 | $58K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.2% | 10,985 | $52K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 4,057 | $43K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 140 | $43K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 2,015 | $36K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 2,021 | $31K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 1,786 | $28K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 242 | $27K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 74 | $24K |
| 71045 | Radiologic examination, chest; single view | <1% | 695 | $23K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,319 | $21K |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 392 | $20K |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 30 | $20K |
| 97162 | <1% | 256 | $20K | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 1,077 | $19K |
| 80320 | <1% | 512 | $17K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 181 | $17K |
| 86803 | <1% | 638 | $16K | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 205 | $15K |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 1,554 | $15K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 68 | $13K |
| 80061 | Lipid panel | <1% | 758 | $13K |
| 84484 | <1% | 544 | $13K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 270 | $13K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 268 | $11K |
| 87653 | <1% | 302 | $11K | |
| 86140 | <1% | 880 | $10K | |
| J3490 | Unclassified drugs | <1% | 1,059 | $8K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 48 | $8K |
| A9270 | Non-covered item or service | <1% | 11,417 | $8K |
| 96367 | <1% | 49 | $8K | |
| 83721 | <1% | 353 | $7K | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 1,038 | $6K |
| 64483 | <1% | 14 | $6K | |
| 81003 | <1% | 2,100 | $6K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 234 | $5K |
| 83690 | <1% | 832 | $5K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 232 | $5K |
| 94729 | <1% | 570 | $5K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 97 | $5K |
| 83605 | <1% | 165 | $5K | |
| 94010 | <1% | 306 | $4K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 66 | $4K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 14 | $4K |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 68 | $4K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 97 | $4K |
| 86850 | <1% | 558 | $4K | |
| 80055 | <1% | 121 | $4K | |
| 80306 | <1% | 457 | $3K | |
| 99233 | Hospital visit by a doctor, follow-up day (complex) | <1% | 84 | $3K |
| 85379 | <1% | 146 | $3K | |
| 80081 | <1% | 69 | $3K | |
| 82728 | <1% | 139 | $3K | |
| 85014 | <1% | 489 | $3K | |
| 83735 | <1% | 375 | $3K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 74 | $3K |
| 87581 | <1% | 74 | $2K | |
| 87486 | <1% | 74 | $2K | |
| 93296 | <1% | 172 | $2K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 77 | $2K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 14 | $2K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 55 | $2K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 126 | $2K |
| 85018 | <1% | 482 | $2K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 15 | $2K |
| 85610 | <1% | 675 | $2K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 48 | $2K |
| 87070 | <1% | 41 | $2K | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 1,097 | $2K |
| 86701 | <1% | 153 | $2K | |
| 82950 | <1% | 261 | $2K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 2,263 | $1K |
| U0001 | Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel | <1% | 13 | $1K |
| U0004 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r | <1% | 13 | $1K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 844 | $1K |
| 84145 | <1% | 51 | $1K | |
| 90686 | <1% | 58 | $864.81 | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 111 | $823.28 |
| J2704 | Injection, propofol, 10 mg | <1% | 1,720 | $714.73 |
| 80076 | <1% | 16 | $711.57 | |
| 84703 | <1% | 170 | $652.90 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 831 | $543.10 |
| 87186 | <1% | 54 | $523.47 | |
| 81025 | <1% | 125 | $427.92 | |
| 83550 | <1% | 39 | $414.49 | |
| 94726 | <1% | 13 | $400.78 | |
| 83540 | <1% | 39 | $390.30 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 712 | $389.91 |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 66 | $370.70 |
| 94060 | <1% | 12 | $358.91 | |
| 85652 | <1% | 68 | $321.75 | |
| 97161 | <1% | 13 | $283.60 | |
| 88738 | <1% | 44 | $190.05 | |
| 82948 | <1% | 34 | $169.52 | |
| 85730 | <1% | 77 | $161.70 | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 112 | $144.04 |
| 73630 | <1% | 15 | $106.12 | |
| 87340 | <1% | 12 | $98.38 | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 40 | $92.58 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,055 | $60.52 |
| 81000 | <1% | 17 | $28.63 | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 105 | $18.89 |
| 36415 | Collection of venous blood by venipuncture | <1% | 57 | $18.24 |
| 83615 | <1% | 16 | $12.36 | |
| J2060 | Injection, lorazepam, 2 mg | <1% | 38 | $7.98 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 58 | $5.63 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 25 | $1.28 |
| J7120 | Ringers lactate infusion, up to 1000 cc | 0% | 75 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMOORE, SARAH (DIRECTOR OF REVENUE CYCLE)
| Provider | Location | Paid |
|---|---|---|
| Developmental Fx-The Developmental & Fragile X Resource Center | Denver, CO | $536K |
| Winnebago Co SP Ed Coop | Rockton, IL | $475K |
| Del Mar Family Eye Care, PC | Aurora, CO | $187K |
| Valley View Hospital Association | Glenwood Springs, CO | $34K |
| Valley View Hospital Association | Silt, CO | $32K |
| Valley View Hospital Association | Silt, CO | $8K |
| Valley View Hospital Association | Eagle, CO | $3K |
| Valley View Hospital Association | Glenwood Springs, CO | $2K |
| Valley View Hospital Association | Basalt, CO | $716.91 |
| Valley View Hospital Association | Basalt, CO | $199.02 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.